Zyban: Clinically Proven Smoking Cessation Therapy
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $2.58 | $68.80 $51.60 (25%) | 🛒 Add to cart |
| 30 | $2.01 | $103.20 $60.20 (42%) | 🛒 Add to cart |
| 60 | $1.15 | $206.40 $68.80 (67%) | 🛒 Add to cart |
| 90 | $0.86 | $309.60 $77.40 (75%) | 🛒 Add to cart |
| 120 | $0.72 | $412.80 $86.00 (79%) | 🛒 Add to cart |
| 180 | $0.65 | $619.20 $116.10 (81%) | 🛒 Add to cart |
| 270 | $0.57 | $928.80 $154.80 (83%) | 🛒 Add to cart |
| 360 | $0.50
Best per pill | $1238.40 $180.60 (85%) | 🛒 Add to cart |
Similar products
Zyban (bupropion hydrochloride) is a prescription medication specifically developed to aid in smoking cessation. As a non-nicotine therapy, it functions by targeting neurochemical pathways associated with nicotine addiction and withdrawal. Clinically demonstrated to double quit rates compared to placebo, it represents a cornerstone pharmacological intervention for tobacco dependence. This sustained-release formulation requires proper medical supervision and a structured quitting plan for optimal efficacy.
Features
- Active ingredient: Bupropion hydrochloride (150 mg sustained-release tablets)
- FDA-approved for smoking cessation
- Non-nicotine mechanism of action
- Gradual release formulation for stable plasma concentrations
- Requires prescription and medical supervision
- Typically administered as part of comprehensive cessation counseling
Benefits
- Reduces nicotine craving and withdrawal symptoms
- Decreases the rewarding effects of smoking if smoking continues
- Eliminates nicotine exposure from cessation therapy itself
- Provides structured pharmacological support during quitting attempt
- Can be used concurrently with nicotine replacement therapy (under medical guidance)
- Supports long-term abstinence through neurochemical adaptation
Common use
Zyban is indicated as an aid to smoking cessation treatment in adults. It is typically prescribed for patients motivated to quit smoking who require pharmacological support to manage withdrawal symptoms and cravings. Treatment should be initiated while the patient is still smoking, with a target quit date set during the second week of treatment. The medication is most effective when combined with behavioral support and counseling.
Dosage and direction
The recommended dosage is 150 mg once daily for the first 3 days, followed by 150 mg twice daily (with at least 8 hours between doses). Treatment should continue for 7-12 weeks, with longer treatment considered for those who successfully quit but require ongoing support. Tablets should be swallowed whole and not crushed, chewed, or divided. Doses should not exceed 300 mg per day. The last dose should not be taken too close to bedtime due to potential insomnia.
Precautions
Patients should be monitored for neuropsychiatric symptoms including agitation, hostility, depression, and suicidal thoughts. Caution is required in patients with hepatic or renal impairment, requiring dosage adjustment. Use with caution in patients with history of seizures, eating disorders, or head trauma. May elevate blood pressure—regular monitoring recommended. Not recommended during abrupt discontinuation of alcohol or sedatives.
Contraindications
Contraindicated in patients with seizure disorder or history of seizures. Should not be used in patients with current or prior diagnosis of bulimia or anorexia nervosa. Contraindicated in patients undergoing abrupt discontinuation of alcohol or benzodiazepines. Not for use in patients taking MAO inhibitors (within 14 days). Contraindicated in patients with known hypersensitivity to bupropion.
Possible side effects
Common side effects include dry mouth (≈10%), insomnia (30-40%), nausea, and headache. Less frequently, patients may experience tremor, rash, sweating, or tinnitus. Serious side effects requiring immediate medical attention include seizures (≈0.1%), severe allergic reactions, hypertension, and neuropsychiatric symptoms. Most side effects are dose-dependent and often diminish with continued treatment.
Drug interaction
Contraindicated with MAO inhibitors. May interact with drugs that lower seizure threshold (antidepressants, antipsychotics, theophylline, systemic corticosteroids). Can affect metabolism of drugs metabolized by CYP2D6 (including some antidepressants, antipsychotics, beta-blockers, and antiarrhythmics). Caution with levodopa and amantadine. May potentiate effects of drugs affecting dopamine.
Missed dose
If a dose is missed, it should be skipped unless there are at least 8 hours until the next scheduled dose. Patients should never take double or extra doses to make up for a missed dose. Maintaining consistent dosing is important for therapeutic effect, but single missed doses generally don’t significantly impact overall efficacy.
Overdose
Overdose may cause seizures, hallucinations, loss of consciousness, tachycardia, and fever. Large overdoses may result in status epilepticus. Medical attention should be sought immediately. Treatment is supportive and symptomatic, with ECG monitoring recommended. There is no specific antidote; benzodiazepines may be used for seizure control.
Storage
Store at room temperature (15-30°C/59-86°F) in original container. Protect from light and moisture. Keep tightly closed and out of reach of children. Do not use if tablets are crushed, broken, or otherwise damaged. Properly dispose of unused medication according to local regulations.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Zyban is a prescription medication that should only be used under appropriate medical supervision. Individual results may vary. Patients should consult their healthcare provider for personalized medical advice and to discuss potential risks and benefits.
Reviews
Clinical studies demonstrate approximately 44% continuous abstinence rates at end of treatment versus 19% for placebo. Long-term follow-up shows approximately 23% abstinence at one year versus 12% for placebo. Patient reports frequently note reduced craving intensity and improved ability to resist smoking triggers. Some users report side effects affecting treatment continuation, emphasizing the need for individualized medical supervision.